Differential role of mGlu1 and mGlu5 receptors in rat hippocampal slice models of ischemic tolerance
- 28 June 2007
- journal article
- Published by Wiley in European Journal of Neuroscience
- Vol. 25 (12), 3597-3604
- https://doi.org/10.1111/j.1460-9568.2007.05614.x
Abstract
Activation of glutamate receptors has been proposed as a key factor in the induction of ischemic tolerance. We used organotypic rat hippocampal slices exposed to 30 min oxygen-glucose deprivation (OGD) to evaluate postischemic pyramidal cell death in the CA1 subregion. In this model, 10 min exposure to OGD 24 h before the exposure to toxic OGD was not lethal and reduced the subsequent OGD neurotoxicity by approximately 53% (ischemic preconditioning). Similarly, a 30 min exposure to the group I mGlu receptor agonist DHPG (10 microM) significantly reduced OGD neurotoxicity 24 h later (pharmacological preconditioning). Ischemic tolerance did not develop when either the selective mGlu1 antagonists LY367385 and 3-MATIDA or the AMPA/KA antagonist CNQX were present in the incubation medium during exposure to sublethal OGD. Neither the NMDA antagonist MK801 nor the mGlu5 antagonist MPEP affected the preconditioning process. On the other hand, pharmacological preconditioning was prevented not only by LY367385 or CNQX, but also by MPEP. In preconditioned slices, the toxic responses to AMPA or NMDA were reduced. The neurotoxicty of 100 microM DHPG in slices simultaneously exposed to a mild (20 min) OGD was differentially altered in the two preconditioning paradigms. After ischemic preconditioning, DHPG neurotoxicity was reduced in a manner that was sensitive to LY367385 but not to MPEP, whereas after pharmacological preconditioning it was enhanced in a manner that was sensitive to MPEP but not to LY367385. Our results show that mGlu1 and mGlu5 receptors are differentially involved in the induction and expression of ischemic tolerance following two diverse preconditioning stimuli.Keywords
This publication has 34 references indexed in Scilit:
- Cerebral preconditioning and ischaemic toleranceNature Reviews Neuroscience, 2006
- Activation of Neuroprotective Pathways by Metabotropic Group I Glutamate Receptors: A Potential Target for Drug Discovery?Annals of the New York Academy of Sciences, 2005
- Activation of Neuroprotective Pathways by Metabotropic Group I Glutamate Receptors: A Potential Target for Drug Discovery?Annals of the New York Academy of Sciences, 2005
- Epsilon Protein Kinase C Mediated Ischemic Tolerance Requires Activation of the Extracellular Regulated Kinase Pathway in the Organotypic Hippocampal SliceJournal of Cerebral Blood Flow & Metabolism, 2004
- Neuroprotection against NMDA excitotoxicity by group I metabotropic glutamate receptors is associated with reduction of NMDA stimulated currentsExperimental Neurology, 2003
- The distinct role of mGlu1 receptors in post-ischemic neuronal deathTrends in Pharmacological Sciences, 2003
- Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity?Neuropharmacology, 2002
- Immunohistochemical localization of the mGluR1? metabotropic glutamate receptor in the adult rodent forebrain: Evidence for a differential distribution of mGluR1 splice variantsJournal of Comparative Neurology, 1998
- Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brainJournal of Comparative Neurology, 1995
- Distribution of the mRNA for a metabotropic glutamate receptor (mGluR1) in the central nervous system: An in situ hybridization study in adult and developing ratJournal of Comparative Neurology, 1992